Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nasal sprays for treating COVID-19: a scientific note
Vivek P. Chavda, Kajal Baviskar, Dixa A. Vaghela, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 249-265
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Conventional vaccination methods: Inactivated and live attenuated vaccines
Terrick Andey, Shailvi Soni, Shail Modi
Elsevier eBooks (2024), pp. 37-50
Closed Access | Times Cited: 7
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Fabio Sonvico, Gaia Colombo, Eride Quarta, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1115-1130
Open Access | Times Cited: 14
The role of engineered materials in mucosal vaccination strategies
Behnaz Eshaghi, Alex Schudel, Ilin Sadeghi, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 1, pp. 29-45
Closed Access | Times Cited: 12
Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge
Xiaoquan Wang, Jing Dai, Wenhao Yang, et al.
Veterinary Research (2025) Vol. 56, Iss. 1
Open Access
Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy
Daniele Focosi, Fabrizio Maggi
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 7
Proteogenomics and immunopeptidomics in the development of advanced vaccines
Bedanta Bhattacharjee, Rajashri Bezbaruah, Damanbhalang Rynjah, et al.
Elsevier eBooks (2024), pp. 455-475
Closed Access | Times Cited: 2
Nanoparticle-based vaccines and future vaccine technologies
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 477-495
Closed Access | Times Cited: 2
Novel strategies in systemic and local administration of therapeutic monoclonal antibodies
Monika Prašnikar, Maja Bjelošević Žiberna, Mirjam Gosenca Matjaž, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124877-124877
Open Access | Times Cited: 2
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics
Vivek P. Chavda, Nidhi Raval, Soham Sheta, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
Jens Peter Klußmann, Maria Grosheva, Peter Meiser, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2
Fabiola Guareschi, Elena Del Favero, Caterina Ricci, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 193, pp. 106673-106673
Open Access | Times Cited: 5
History of vaccination
Vivek P. Chavda, Pankti C. Balar, Vasso Apostolopoulos
Elsevier eBooks (2024), pp. 1-12
Closed Access | Times Cited: 1
Effects of Nozzle Retraction Elimination on Spray Distribution in Middle-Posterior Turbinate Regions: A Comparative Study
Amr Seifelnasr, Xiuhua Si, Jinxiang Xi
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 683-683
Open Access | Times Cited: 1
Antiviral Potential of Azelastine against Major Respiratory Viruses
Katrin Fischhuber, Zoltán Bánki, Janine Kimpel, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2300-2300
Open Access | Times Cited: 3
Safety and efficacy of lentinan nasal drops in patients infected with the variant of COVID-19: a randomized, placebo-controlled trial
Wenhan Fan, Benming You, Xinyu Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Interaction between anti-COVID compounds across spike protein subunits influences their inhibition potential
Medhat Farag, Aslam Pathan, Nawaf Aldoij
Annals of Phytomedicine An International Journal (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Towards Resilient Public Places and Buildings to Pandemics
Ali Cheshmehzangi, Maycon Sedrez, Ayotunde Dawodu, et al.
(2024), pp. 153-161
Closed Access
Oral Vaccine Delivery
Pankti C. Balar, Vidhi A. Modh, Sanjay Chauhan, et al.
(2024), pp. 345-366
Closed Access
Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication
David A. Davis, Ashwin Nair, Yana Astter, et al.
RSC Medicinal Chemistry (2024)
Closed Access
VACINAS, AVANÇOS BIOTECNOLOGICOS E O PAPEL DO BIOMÉDICO
João Vitor de Souza Lima, Luciano Lobo Gatti, Douglas Fernandes da Silva
(2023), pp. 101-119
Open Access
O USO DO ÁCIDO HIALURÔNICO NA HARMONIZAÇÃO E REJUVENECIMENTO FACIAL: UMA REVISÃO LITERÁRIA
Maria Eduarda Gonçalves, Thauany Domingues Gonçalves
(2023), pp. 81-100
Open Access
AVALIAÇÃO DA TOXICIDADE DA ASSOCIAÇÃO DE ÁCIDO ASCÓRBICO/ SULFATO FERROSO COMPARADO COM O QUELATO DE BIS-GLICINATO FERROSO EM RATOS WISTAR
Artur Bernardo Ribeiro Bellomi, Maria Eduarda Malpeli Presotto, Victor Hugo Elias de Oliveira, et al.
(2023), pp. 28-48
Open Access
A dinâmica do conhecimento biomédico 2
Claudiane Ayres
(2023)
Open Access
GESTÃO DE RISCOS DINÂMICOS PARA PROJETOS DE DISPOSITIVOS DE ASSISTÊNCIA VENTRICULAR COM CONCEITO DE SEGURANÇA INERENTE
Jeferson Cerqueira Dias, Jônatas Cerqueira Dias, Diolino José dos Santos Filho
(2023), pp. 64-80
Open Access
ANALIAÇÃO DO EFEITO ANTI-TOXOPLASMA GONDII DE COMPOSTOS METALOCOMPLEXOS COORDENADOS OU NÃO A SULFADIAZINA
Ary Guedes Porto Duarte
(2023), pp. 49-63
Open Access
Page 1 - Next Page

Scroll to top